Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhances GSK-3 Inhibitor Delivery for Amyloid-Beta Plaque Reduction

Scientific Reports
Po-Hung HsuHao-Li Liu

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that is the leading cause of age-related dementia. Currently, therapeutic agent delivery to the CNS is a valued approach for AD therapy. Unfortunately, the CNS penetration is greatly hampered by the blood-brain barrier (BBB). Focused-ultrasound (FUS) has been demonstrated to temporally open the BBB, thus promoting therapeutic agent delivery to the CNS. Recently, the BBB opening procedure was further reported to clear the deposited Aβ plaque due to microglia activation. In this study, we aimed to evaluate whether the use of FUS-induced BBB opening to enhance GSK-3 inhibitor delivery, which would bring additive effect of Aβ plaque clearance by FUS with the reduction of Aβ plaque synthesis by GSK-3 inhibitor in an AD mice model. FUS-induced BBB opening on APPswe/PSEN1-dE9 transgenic mice was performed unilaterally, with the contralateral hemisphere serving as a reference. GSK-3 level was confirmed by immunohistochemistry (IHC) and autoradiography (ARG) was also conducted to quantitatively confirm the Aβ plaque reduction. Results from IHC showed GSK-3 inhibitor effectively reduced GSK-3 activity up to 61.3% with the addition of FUS-BBB opening and confirming the proposed thera...Continue Reading

References

Oct 6, 1997·The Journal of Biological Chemistry·M HongV M Lee
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Mar 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Batya PlotkinHagit Eldar-Finkelman
Aug 21, 2003·The Journal of Biological Chemistry·Ratan BhatJesús Avila
Mar 23, 2004·Current Medicinal Chemistry·M Alonso, A Martinez
Aug 19, 2004·The International Journal of Neuropsychopharmacology·Todd D GouldHusseini K Manji
Nov 24, 2004·Trends in Pharmacological Sciences·Laurent MeijerPaul Greengard
Sep 6, 2005·Biochemical and Biophysical Research Communications·Hirotada AkiyamaTakafumi Uchida
Nov 16, 2005·Ultrasound in Medicine & Biology·Nathan McDannoldKullervo Hynynen
Apr 14, 2006·Current Alzheimer Research·Alberto Gómez-RamosJesús Avila
Sep 1, 2006·Neurochemical Research·Richard S JopeEléonore Beurel
Oct 28, 2008·Journal of Alzheimer's Disease : JAD·Ana Martinez, Daniel I Perez
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Seok Rye ChoiHank F Kung
Jul 1, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Laura Del BarrioManuela G López
Dec 14, 2012·Journal of Alzheimer's Disease : JAD·David T ChienHartmuth C Kolb
Aug 21, 2013·Journal of Alzheimer's Disease : JAD·David T ChienHartmuth C Kolb
Oct 22, 2013·Clinical Therapeutics·Haakon B Nygaard
Mar 13, 2015·Science Translational Medicine·Gerhard Leinenga, Jürgen Götz
Feb 20, 2016·Nature Communications·Dag SehlinStina Syvänen
Aug 30, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association

❮ Previous
Next ❯

Citations

Jun 2, 2020·Frontiers in Bioengineering and Biotechnology·Yi KungWen-Shiang Chen
Dec 14, 2018·Dementia & Neuropsychologia·Rodrigo Marmo da Costa E SouzaVictor Ribeiro Xavier Costa
Feb 24, 2019·Critical Care : the Official Journal of the Critical Care Forum·Shouri LahiriMaya Koronyo-Hamaoui
Dec 4, 2019·Advanced Drug Delivery Reviews·Rucha PanditJürgen Götz
Jan 14, 2021·Brain Sciences·Giuseppe Roberto GiammalvaRosario Maugeri
Jun 30, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tao SunCynthia A Lemere
Sep 26, 2021·Translational Neurodegeneration·Francisca MonteiroFilipe S Silva

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

ImageJ
Multi
GraphPad
Prism
Gauge

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.